secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Oncology, Inc. (CRDF)
CIK:        0001213037
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001628280-22-001522
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardiff Oncology grants 55,008 stock options to new employee as inducement
--------------------------------------------------------------------------

- Non-qualified stock options for 55,008 shares granted on Jan 31, 2022 to one new employee.
- Exercise price of $3.38 per share, equal to Jan 31 closing price.
- Options vest over 4 years: 25% at 1-year anniversary, remainder monthly over 36 months.
- Grant made under Nasdaq Listing Rule 5635(c)(4) as inducement material to employment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213037/000162828022001522/0001628280-22-001522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213037/000162828022001522/crdf-20220131.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-001522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer